Gene · 285220
EPHA6: EPH receptor A6
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EPHA6: EPH receptor A6. Genes, record 285220. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/285220
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UF33 | Ephrin type-A receptor 6 | 1,036 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents31
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025529142 A | 2025-09-04 | 1417 | Q9UF33 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1417 | Q9UF33 | Espacenet |
| JP 2024514157 A | 2024-03-28 | 217 | Q9UF33 | Espacenet |
| KR 1020240007143 A | 2024-01-16 | 217 | Q9UF33 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 803 | Q9UF33 | Espacenet |
| US 7795412 B2 | 2010-09-14 | 104 | Q9UF33 | Espacenet |
| JP 2010527589 A | 2010-08-19 | 8 | Q9UF33 | Espacenet |
| US 7589172 A | 2009-09-15 | 104 | Q9UF33 | Espacenet |
| US 7582293 A | 2009-09-01 | 104 | Q9UF33 | Espacenet |
| JP 2009527227 A | 2009-07-30 | 171 | Q9UF33 | Espacenet |
1 to 10 of 31
See all 31 patentsDrugs1
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action |
|---|---|---|---|
| VANDETANIB | CHEMBL24828 | Ephrin receptor inhibitor | INHIBITOR |
Source ChEMBL
Trials97
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT06482086 | VANDETANIB | PHASE2 | ClinicalTrials.gov | |
| NCT04211337 | VANDETANIB | PHASE3 | 2024-06-13 | ClinicalTrials.gov |
| NCT03630120 | VANDETANIB | PHASE2 | 2021-01-22 | ClinicalTrials.gov |
| NCT03291379 | VANDETANIB | EARLY_PHASE1 | 2021-02-03 | ClinicalTrials.gov |
| NCT02638428 | VANDETANIB | PHASE2 | ClinicalTrials.gov | |
| NCT02530411 | VANDETANIB | PHASE2 | ClinicalTrials.gov | |
| NCT02495103 | VANDETANIB | PHASE1/PHASE2 | 2021-01-26 | ClinicalTrials.gov |
| NCT02299999 | VANDETANIB | PHASE2 | ClinicalTrials.gov | |
| NCT02117167 | VANDETANIB | PHASE2 | ClinicalTrials.gov | |
| NCT02109250 | VANDETANIB | ClinicalTrials.gov |
1 to 10 of 97
See all 97 trialsNIH grants447
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EPHA6 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30AG062715 | Wisconsin Alzheimer's Disease Research Center | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 2 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 2 | 2025 |
| P30CA069533 | OHSU Knight Cancer Institute | 2 | 2025 |
| P30ES023513 | UC Davis Environmental Health Sciences Core Center | 2 | 2025 |
| R01AG072758 | Maladaptive antiviral pathways in Alzheimer's disease | 2 | 2025 |
| R01AG074541 | cGAS inhibitors for Alzheimer's disease treatment | 2 | 2025 |
1 to 10 of 447Source NIH's project files
See all 447 nih grantsPapers448
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Weighted Single-Step Genomic Evaluation of Body Structural Traits for Early Selection of Growth Performance in Thai Swamp Buffalo. | Animals (Basel) | 2026 | 42450718 | PubTator, text mining | PubMed |
| Machine Learning-Based Prediction of Masaoka-Koga Stage and WHO Histological Risk Group in Thymic Epithelial Tumors Using Biomarker Combinations. | Diagnostics (Basel) | 2026 | 42449899 | PubTator, text mining | PubMed |
| Identification of telomere-related genes in the progression of colon adenocarcinoma: a bioinformatics analysis. | J Gastrointest Oncol | 2026 | 42434232 | PubTator, text mining | PubMed |
| Mathematical Modeling of Human Retinal Vascular Pattern Around the Foveal Avascular Zone. | Transl Vis Sci Technol | 2026 | 41769944 | PubTator, text mining | PubMed |
| Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm. | PLoS Comput Biol | 2026 | 41701761 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| From thought to action: The organization of spinal projecting neurons. | Cell Rep | 2025 | 40818073 | PubTator, text mining | PubMed |
| Mef2c Controls Postnatal Callosal Axon Targeting by Regulating Sensitivity to Ephrin Repulsion. | J Neurosci | 2025 | 40228894 | PubTator, text mining | PubMed |
| Illuminating the dark kinome: utilizing multiplex peptide activity arrays to functionally annotate understudied kinases. | Cell Commun Signal | 2024 | 39415254 | PubTator, text mining | PubMed |
| [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation]. | Zhonghua Zhong Liu Za Zhi | 2024 | 39034804 | PubTator, text mining | PubMed |
1 to 10 of 448
See all 448 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/285220
GET https://conductscience.org/api/genes/v1/285220/patents?page=2